Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Higinio Dopeso

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Nature Communications|November 26, 2014
Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFRAnne-Theres Henze, Boyan K Garvalov, Sascha Seidel, et al.
Clinical Epigenetics|April 24, 2021
Identification of ZBTB18 as a novel colorectal tumor suppressor gene through genome-wide promoter hypermethylation analysisSarah Bazzocco, Higinio Dopeso, Águeda Martínez-Barriocanal, et al.
Cancer Research|October 1, 2009
An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expressionZiqiang Yuan, Joongho Shin, Andrew Wilson, et al.
Journal of Clinical Pathology|November 2, 2022
<i>KIT</i> genetic alterations in breast cancerMahsa Vahdatinia, Fatemeh Derakhshan, Arnaud Da Cruz Paula, et al.
Scientific Reports|February 8, 2017
Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancerElena Andretta, Fernando Cartón-García, Águeda Martínez-Barriocanal, et al.
Cancer Research|September 10, 2009
The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesisHiginio Dopeso, Silvia Mateo-Lozano, Rocco Mazzolini, et al.
Journal of Clinical Pathology|November 5, 2020
Neuroendocrine tumours of the breast: a genomic comparison with mucinous breast cancers and neuroendocrine tumours of other anatomic sitesFresia Pareja, Mahsa Vahdatinia, Caterina Marchio, et al.
British Journal of Cancer|December 6, 2017
Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancerHiginio Dopeso, Paulo Rodrigues, Josipa Bilic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2025
Evolution and co-occurrence of PI3K pathway gene mutations in endometrial carcinoma molecular subtypes at the single-cell levelArnaud Da Cruz Paula, Yingjie Zhu, David N Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
Aprataxin tumor levels predict response of colorectal cancer patients to irinotecan-based treatmentHiginio Dopeso, Silvia Mateo-Lozano, Elena Elez, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Nature Communications|November 26, 2014
Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFRAnne-Theres Henze, Boyan K Garvalov, Sascha Seidel, et al.
Clinical Epigenetics|April 24, 2021
Identification of ZBTB18 as a novel colorectal tumor suppressor gene through genome-wide promoter hypermethylation analysisSarah Bazzocco, Higinio Dopeso, Águeda Martínez-Barriocanal, et al.
Cancer Research|October 1, 2009
An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expressionZiqiang Yuan, Joongho Shin, Andrew Wilson, et al.
Journal of Clinical Pathology|November 2, 2022
<i>KIT</i> genetic alterations in breast cancerMahsa Vahdatinia, Fatemeh Derakhshan, Arnaud Da Cruz Paula, et al.
Scientific Reports|February 8, 2017
Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancerElena Andretta, Fernando Cartón-García, Águeda Martínez-Barriocanal, et al.
Cancer Research|September 10, 2009
The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesisHiginio Dopeso, Silvia Mateo-Lozano, Rocco Mazzolini, et al.
Journal of Clinical Pathology|November 5, 2020
Neuroendocrine tumours of the breast: a genomic comparison with mucinous breast cancers and neuroendocrine tumours of other anatomic sitesFresia Pareja, Mahsa Vahdatinia, Caterina Marchio, et al.
British Journal of Cancer|December 6, 2017
Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancerHiginio Dopeso, Paulo Rodrigues, Josipa Bilic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2025
Evolution and co-occurrence of PI3K pathway gene mutations in endometrial carcinoma molecular subtypes at the single-cell levelArnaud Da Cruz Paula, Yingjie Zhu, David N Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
Aprataxin tumor levels predict response of colorectal cancer patients to irinotecan-based treatmentHiginio Dopeso, Silvia Mateo-Lozano, Elena Elez, et al.
Pageof 5